title: Antifungal drug susceptibility testing. Working Party of the British Society for Antimicrobial chemotherapy.
abstract: This article describes the current situation with regard to intrinsic and acquired resistance to antifungal compounds and progress with the development of standardized methods of susceptibility testing for amphotericin B, flucytosine, and the azoles. Recommendations for testing of isolates from patients destined to receive antifungal drug treatment, or in whom therapeutic failure or relapse is suspected, are presented.
authors.affiliation: Department of Infectious Diseases and Bacteriology, Royal Postgraduate Medical School, London.
authors.forename: T R
authors.initials: TR
authors.lastname: Rogers
authors.forename: R A
authors.initials: RA
authors.lastname: Barnes
authors.forename: D W
authors.initials: DW
authors.lastname: Denning
authors.forename: E G
authors.initials: EG
authors.lastname: Evans
authors.forename: R J
authors.initials: RJ
authors.lastname: Hay
authors.forename: A G
authors.initials: AG
authors.lastname: Prentice
authors.forename: D C
authors.initials: DC
authors.lastname: Speller
authors.forename: D W
authors.initials: DW
authors.lastname: Warnock
authors.forename: R E
authors.initials: RE
authors.lastname: Warren
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D006801:Humans; D008826:Microbial Sensitivity Tests
chemical_list: D000935:Antifungal Agents